<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00843076</url>
  </required_header>
  <id_info>
    <org_study_id>AORT08-PR/VIRO-Stéatose</org_study_id>
    <nct_id>NCT00843076</nct_id>
  </id_info>
  <brief_title>Impact of Hepatitis C Virus Variability on Steatosis</brief_title>
  <acronym>Viro-steatosis</acronym>
  <official_title>Impact of the Hepatitis C Virus Variability on Liver Steatosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Tours</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Tours</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic infection by the hepatitis C virus (HCV) is a common cause of liver disease, which&#xD;
      may progress to cirrhosis and eventually liver cancer. The therapeutic indication will depend&#xD;
      mainly on the importance of liver damage (fibrosis), which can be assessed by physical&#xD;
      techniques, blood tests and a liver biopsy. The overall objectives of the project are to&#xD;
      understand how HCV variability may influence the severity of steatosis (accumulation of fat&#xD;
      in the liver), studying 30 patients chronically infected with HCV (half of these patients&#xD;
      infected by HCV genotype 3, versus the other half infected by HCV of another genotype). A&#xD;
      small portion of the biopsy performed for the routine pathology examination will be placed in&#xD;
      special fixation buffer for electron microscopy (EM). Counting and measuring the size of&#xD;
      lipid droplets present in the liver by EM will be used to precisely quantify and characterize&#xD;
      the liver steatosis. A blood sample of patients will also be collected to sequence the viral&#xD;
      genome present in the patient and identify the amino acids involved in an increase in&#xD;
      intracellular accumulation of lipid droplets. This work should clarify the impact of the&#xD;
      viral variability in the severity of steatosis. Ultimately, the identification of viral&#xD;
      sequences responsible for an increase of this phenomenon could be crucial for understanding&#xD;
      the mechanisms involved in the steatosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">27</enrollment>
  <condition>Chronic Hepatitis C</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Liver biopsy&#xD;
&#xD;
      Blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic hepatitis C&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with chronic hepatitis C, naive of an antiviral treatment or after relapse or&#xD;
             non-response for an antiviral treatment stopped for more than 1 year&#xD;
&#xD;
          -  Liver biopsy necessary for the care of the patient&#xD;
&#xD;
          -  Signature of informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients for which the liver biopsy is estimated ≤ 18 mm, so a portion of 3 mm could&#xD;
             not be devoted for the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe ROINGEARD</last_name>
    <role>Study Director</role>
    <affiliation>INSERM ERI 19</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CH de Blois</name>
      <address>
        <city>Blois</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Bourges</name>
      <address>
        <city>Bourges</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Châteauroux</name>
      <address>
        <city>Chateauroux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH de Dreux</name>
      <address>
        <city>Dreux</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHR Orléans</name>
      <address>
        <city>Orleans</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU de Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2013</verification_date>
  <study_first_submitted>February 12, 2009</study_first_submitted>
  <study_first_submitted_qc>February 12, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 13, 2009</study_first_posted>
  <last_update_submitted>November 8, 2013</last_update_submitted>
  <last_update_submitted_qc>November 8, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 11, 2013</last_update_posted>
  <responsible_party>
    <name_title>University Hospital, Tours</name_title>
    <organization>University Hospital, Tours</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>Hepatitis C, Chronic</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

